CA
NZ
UK
AU
IND
US
Lockheed Martin Corp. (NYSE: LMT) demonstrated a strong financial performance for the second quarter of 2026, reporting earnings that substantially surpassed the consensus estimate. This strong performance reflects the company's effective execution and the increasing demand for defense products amid ongoing geopolitical tensions, including …
One World Products, Inc. (OTC: OWPC) has undergone a significant leadership change, with Dr. Kenneth L. Perego being removed from its Board of Directors, effective immediately.
Both Ford and General Motors received upward rating adjustments from Jefferies, with Ford's price target rising to $17.50 and GM's to $99. This is significant for investors as it indicates a potential upside of 21% for Ford and 17% for GM over the next …
L'Air Liquide reported strong growth prospects in its Q2 results, underscoring its commitment to sustainability and innovation. This signals a positive trajectory for investors, especially in industrial sectors focusing on eco-friendly operations.Key HighlightsL'Air Liquide emphasized its focus on low-carbon solutions during its latest earnings …
Michelin's brand growth in H1 2026 contributed to improving margins, indicating stronger operational performance during a period of market uncertainty. This resilience underscores the company's ability to navigate challenges, potentially attracting investor interest in its operational strategy.Key HighlightsMichelin's brand expansion resulted in notable improvement …
Preformed Line Products Company (NASDAQ: PLPC) has made a significant move in its growth strategy by acquiring a new facility for an estimated CAD 23.5 million (around $16.7 million). This investment is aimed at expanding its manufacturing capacity, providing the necessary infrastructure to support …
Spruce Biosciences (NASDAQ: SPRB) has appointed Adrian Quartel, M.D. FFPM, as its new Chief Medical Officer, bringing substantial rare disease and clinical development expertise to the biopharmaceutical firm. This strategic leadership adjustment sees Dr. Quartel taking over from Dr.
OPKO Health (NASDAQ: OPK) delivered earnings per share of -$0.01 for the quarter ended June 30 2026, surpassing the consensus estimate. Revenue expanded to $163.5 million, while operating loss narrowed to $7.0 million, a notable improvement from a $60.0 million loss a year earlier. …
ProMIS Neurosciences Inc. has revealed encouraging interim results from its Phase 1b clinical trial for PMN310, an innovative treatment targeting Alzheimer’s disease. Over a six-month evaluation period, the trial demonstrated no brain swelling cases, a finding important for ensuring safety in Alzheimer’s therapies. The …
EUDA Health Holdings Ltd. has entered into a Memorandum of Understanding (MOU) aimed at developing innovative stem cell therapies for cancer treatment. This strategic collaboration with GO POSB Organoids and Shenzhen Inno marks a significant step for EUDA as it seeks to bolster its …
Please wait processing your request...